1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. 製品タイプ別スニペット
3.2. 技術別スニペット
3.3. 用途別スニペット
3.4. エンドユーザー別スニペット
3.5. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 慢性疾患の増加と技術の進歩
4.1.1.2. XX
4.1.2. 阻害要因
4.1.2.1. 高い設備コスト
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
6. 製品タイプ別
6.1. 製品紹介
6.1.1. 製品タイプ別市場規模分析および前年比成長率分析(%)
6.1.2. 市場魅力度指数(製品タイプ別
6.2. 試薬・消耗品*市場
6.2.1. はじめに
6.2.2. 市場規模分析と前年比成長率分析(%)
6.2.3. 抗体
6.2.4. アッセイとキット
6.2.5. その他
6.3. 装置
6.3.1. セルアナライザー
6.3.2. セルソーター
6.4. ソフトウェア
6.5. アクセサリー
6.6. サービス
7. 技術別
7.1. 導入
7.1.1. 市場規模分析および前年比成長率分析(%), 技術別
7.1.2. 市場魅力度指数、技術別
7.2. セルベース
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. ビーズベース
8. 用途別
8.1. 導入
8.1.1. 用途別市場規模分析および前年比成長率分析(%)
8.1.2. 市場魅力度指数、用途別
8.2. 調査
8.2.1. 序論
8.2.2. 市場規模分析と前年比成長率分析 (%)
8.2.3. 創薬
8.2.4. 幹細胞研究
8.2.5. 免疫学研究
8.2.6. アポトーシス解析
8.2.7. 細胞選別とバイアビリティ評価
8.3. 臨床
8.3.1. 癌の検出
8.3.2. 臓器移植
8.3.3. 免疫不全症
8.3.4. 血液学
8.4. 工業
9. エンドユーザー別
9.1. 導入
9.1.1. 市場規模分析および前年比成長率分析(%), エンドユーザー別
9.1.2. 市場魅力度指数、エンドユーザー別
9.2. 製薬・バイオテクノロジー企業
9.2.1. はじめに
9.2.2. 市場規模分析と前年比成長率分析(%)
9.3. 学術・研究機関
9.4. 病院・臨床検査機関
9.5. 血液銀行
9.6. その他
10. 地域別
10.1. はじめに
10.1.1. 地域別市場規模分析および前年比成長率分析(%)
10.1.2. 市場魅力度指数、地域別
10.2. 北米
10.2.1. 序論
10.2.2. 主な地域別ダイナミクス
10.2.3. 市場規模分析および前年比成長率分析(%), 製品タイプ別
10.2.4. 市場規模分析およびYoY成長率分析(%)、技術別
10.2.5. 市場規模分析および前年比成長率分析(%)、アプリケーション別
10.2.6. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
10.2.7. 市場規模分析および前年比成長率分析(%)、国別
10.2.7.1. 米国
10.2.7.2. カナダ
10.2.7.3. メキシコ
10.3. ヨーロッパ
10.3.1. はじめに
10.3.2. 主な地域別ダイナミクス
10.3.3. 市場規模分析および前年比成長率分析(%), 製品タイプ別
10.3.4. 市場規模分析およびYoY成長率分析(%)、技術別
10.3.5. 市場規模分析および前年比成長率分析(%)、アプリケーション別
10.3.6. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
10.3.7. 市場規模分析および前年比成長率分析(%)、国別
10.3.7.1. ドイツ
10.3.7.2. イギリス
10.3.7.3. フランス
10.3.7.4. スペイン
10.3.7.5. イタリア
10.3.7.6. その他のヨーロッパ
10.4. 南米
10.4.1. はじめに
10.4.2. 地域別主要市場
10.4.3. 市場規模分析および前年比成長率分析(%), 製品タイプ別
10.4.4. 市場規模分析およびYoY成長率分析(%)、技術別
10.4.5. 市場規模分析およびYoY成長率分析(%)、アプリケーション別
10.4.6. 市場規模分析および前年比成長率分析(%)、エンドユーザー別
10.4.7. 市場規模分析および前年比成長率分析(%)、国別
10.4.7.1. ブラジル
10.4.7.2. アルゼンチン
10.4.7.3. その他の南米諸国
10.5. アジア太平洋
10.5.1. 序論
10.5.2. 主な地域別ダイナミクス
10.5.3. 市場規模分析および前年比成長率分析(%), 製品タイプ別
10.5.4. 市場規模分析とYoY成長率分析(%), 技術別
10.5.5. 市場規模分析および前年比成長率分析(%), アプリケーション別
10.5.6. 市場規模分析および前年比成長率分析 (%)、エンドユーザー別
10.5.7. 市場規模分析および前年比成長率分析(%)、国別
10.5.7.1. 中国
10.5.7.2. インド
10.5.7.3. 日本
10.5.7.4. 韓国
10.5.7.5. その他のアジア太平洋地域
10.6. 中東・アフリカ
10.6.1. 序論
10.6.2. 主な地域別ダイナミクス
10.6.3. 市場規模分析および前年比成長率分析(%), 製品タイプ別
10.6.4. 市場規模分析とYoY成長率分析(%)、技術別
10.6.5. 市場規模分析および前年比成長率分析(%), アプリケーション別
10.6.6. 市場規模分析および前年比成長率分析(%), エンドユーザー別
11. 競合情勢
11.1. 競争シナリオ
11.2. 市場ポジショニング/シェア分析
11.3. M&A分析
12. 企業プロフィール
12.1. Becton, Dickinson and Company *
12.1.1. 会社概要
12.1.2. 製品ポートフォリオと内容
12.1.3. 財務概要
12.1.4. 主な展開
12.2. Danaher Corporation (Beckman Coulter)
12.3. Thermo Fisher Scientific Inc.
12.4. Agilent Technologies, Inc.
12.5. Bio-Rad Laboratories, Inc.
12.6. Miltenyi Biotec
12.7. Sysmex Corporation
12.8. bioMérieux
12.9. Cytek Biosciences
12.10. Apogee Flow Systems Ltd.
リストは網羅的ではありません
13. 付録
13.1. 会社概要とサービス
13.2. お問い合わせ
The global flow cytometry market reached US$ 4.76 billion in 2023 and is expected to reach US$ 8.24 billion by 2031 growing with a CAGR of 7.1% during the forecast period 2024-2031.
Flow cytometry is an advanced method to identify and quantify the physical and chemical traits of cells or particles suspended in a liquid medium. This technique enables the swift examination of individual cells as they move past a laser beam, where they are illuminated and evaluated based on their light scattering and fluorescence characteristics.
Flow cytometry is a laser-driven technique that identifies and measures different characteristics of cells or particles, such as size, granularity, and specific protein markers using fluorescent labeling. This method allows healthcare professionals to analyze blood, bone marrow, and other bodily fluids samples. It is especially valuable for diagnosing diseases like cancer and infections by detecting and characterizing various cell types.
Market Dynamics: Drivers
Rising incidence of chronic diseases and technological advancements
The demand for the global flow cytometry market is driven by multiple factors. One of the primary factors is the rising incidence of chronic diseases and technological advancements. The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders is significantly driving the demand for advanced diagnostic tools like flow cytometers. Early diagnosis is essential for enhancing patient outcomes in chronic diseases. Flow cytometry provides quick and accurate analysis of cellular characteristics, allowing healthcare professionals to detect abnormalities at earlier stages.
Furthermore, continuous technological advancements in flow cytometry technology, particularly the emergence of high-throughput flow cytometry (HTFC) and spectral flow cytometry, are greatly improving data resolution and facilitating more intricate analyses. HTFC enables the examination of thousands of cells per second, which is vital for extensive research efforts. For instance, systems like HyperCyt allow for swift sample loading from multi-well plates, processing up to 40 wells every minute. This rapid throughput is essential in drug discovery and screening processes, where analyzing large quantities of samples quickly is crucial.
In addition, key players in the industry product launches and approvals that would drive this market growth. For instance, in May 2024, Agilent Technologies Inc. unveiled the NovoCyte Opteon Spectral Flow Cytometer, marking a significant advancement in flow cytometry accessibility. This innovative system establishes a new benchmark for acquiring, analyzing, and reporting flow data across various fields, including basic research, drug discovery, and therapy development.
Also, in January 2024, IDEX Health & Science launched the Semrock line of Nanopede Optical Filters, specifically designed for flow cytometry applications. The Nanopede filters are engineered to provide high transmission rates while effectively blocking unwanted light (optical density OD5) across the spectrum. This ensures that the fluorescence signals collected during flow cytometry are clear and accurate.
Similarly, in November 2023, CD Bioparticles announced the launch of a new range of Flow Cytometry Particles, which includes various types of polystyrene particles specifically designed for calibration and standardization in flow cytometry experiments.
Restraints
Factors such as high equipment costs, and lack of awareness among individuals, are expected to hamper the market.
Segment Analysis
The global flow cytometry market is segmented based on product type, technology, application, end-user, and region.
The reagents and consumables segment accounted for approximately 43.9% of the global flow cytometry market share
The reagents and consumables segment is expected to hold the largest market share over the forecast period. The reagents and consumables segment is a crucial element of the flow cytometry market, significantly contributing to its growth and application across multiple domains. This segment includes a variety of essential products for performing flow cytometry assays, such as antibodies, assays, kits, and various other reagents.
Moreover, key players in the industry have innovative product launches & approvals and technological advancements that would drive this market growth. For instance, in August 2024, Bio-Rad Laboratories, Inc. announced the launch of annexin V conjugated to eight StarBright Dyes: SBUV400, SBUV795, SBV440, SBV515, SBV790, SBB675, SBB765, and SBY800. These new Annexin V StarBright conjugates facilitate the detection of early apoptotic cells through flow cytometry and provide researchers with a broader selection of fluorophore options. This expansion enhances the ability to incorporate apoptosis detection into multicolor immunophenotyping panels for both conventional and full-spectrum flow cytometry applications.
Also, in May 2023, Sysmex Corporation launched its Clinical Flow Cytometry System, which includes the Flow Cytometer XF-1600 and Sample Preparation System PS-10, along with antibody reagents and related products in Japan. The introduction of the XF-1600 is anticipated to greatly enhance workflow efficiency in clinical laboratories by minimizing manual tasks and promoting standardization. This development aligns with Sysmex's dedication to improving diagnostic capabilities and tackling medical challenges through innovative solutions.
Similarly, in March 2024, Beckman Coulter Life Sciences received 510(k) clearance from the Food and Drug Administration (FDA) to distribute its DxFLEX Clinical Flow Cytometer in the United States. This development brings the widely used benchtop IVD flow cytometry system to American laboratories while enhancing their testing capabilities. The DxFLEX system supports up to 13 colors, and additional detectors can be activated as laboratory needs change, eliminating the necessity for new hardware purchases.
Geographical Analysis
North America accounted for approximately 44.8% of the global flow cytometry market share
North America region is expected to hold the largest market share over the forecast period owing to the growing prevalence of chronic diseases, especially cancer and immunodeficiency disorders, which is a significant factor driving the flow cytometry market. The American Cancer Society indicated that around 1.9 million new cancer cases would be diagnosed in the U.S. in 2022, which would drive the need for effective diagnostic tools like flow cytometry. As healthcare professionals increasingly seek faster and more precise diagnostic methods, the importance of flow cytometry continues to rise.
Technological advancements in flow cytometry are significantly enhancing its capabilities, leading to better resolution and sensitivity in quantifying different cell types. Innovations like multi-parameter analysis enable thorough immunophenotyping, which is vital for diagnosing and tracking diseases such as leukemia and lymphoma. Additionally, the launch of new instruments and software solutions is further driving market growth.
Moreover, in this region, a major number of key player's presence, well-advanced healthcare infrastructure, and government initiatives & regulatory support, and investment in research and development would drive this market growth. For instance, in June 2023, in New Jersey, BD (Becton, Dickinson and Company) announced the global launch of a new automated instrument designed for preparing samples for clinical diagnostics using flow cytometry. This innovative system facilitates a complete "walkaway" workflow solution aimed at enhancing standardization and reproducibility in cellular diagnostics.
Also, in May 2023, in New Jersey BD (Becton, Dickinson and Company) announced the global launch of an innovative cell sorting instrument that incorporates two innovative technologies, significantly enhancing the capabilities of flow cytometry.
Market Segmentation
By Product Type
• Reagents and Consumables
o Antibodies
o Assays and kits
o Others
• Instruments
o Cell Analyzers
o Cell Sorters
• Software
• Accessories
• Services
By Technology
• Cell-Based
• Bead-Based
By Application
• Research
o Drug Discovery
o Stem Cell Research
o Immunology Studies
o Apoptosis Analysis
o Cell Sorting and Viability Assessments
• Clinical
o Cancer Detection
o Organ Transplantation
o Immunodeficiency Disorders
o Hematology
• Industrial
By End-User
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Clinical Testing Laboratories
• Blood Banks
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o The rest of South America
• Asia-Pacific
o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the flow cytometry market include Becton, Dickinson and Company, Danaher Corporation (Beckman Coulter), Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Miltenyi Biotec, Sysmex Corporation, bioMérieux, Cytek Biosciences, and Apogee Flow Systems Ltd. among others.
Key Developments
In April 2024, Beckman Coulter Life Sciences introduced the QbD1200+ Total Organic Carbon (TOC) Analyzer. This new instrument simplifies and accelerates the analysis of pharmaceuticals and biopharmaceuticals, providing more robust data. It features streamlined validation processes and encrypted data reporting, ensuring compliance with 21 CFR Part 11 regulations and major global pharmacopeia standards.
In March 2024, Beckman Coulter Life Sciences announced the launch of the CytoFLEX nano Flow Cytometer, a specialized instrument designed for research purposes that significantly enhances the capabilities of flow cytometry. It can detect particles as small as 40 nm, marking a significant improvement over traditional flow cytometers, which typically have higher detection thresholds. This enhanced capability allows researchers to analyze smaller biological entities, such as extracellular vesicles (EVs), that are crucial for understanding various biological processes and diseases.
In January 2024, Cytek Biosciences, Inc. agreed with the Centre for Genomic Regulation (CRG) and Pompeu Fabra University (UPF). This collaboration aims to foster technological innovation and expedite discoveries for the scientific community.
In January 2023, METAFORA Biosystems announced the launch of METAflow, its digital flow cytometry platform, into the Research Use Only (RUO) market. METAflow features a sophisticated suite of unsupervised algorithms that streamline the analysis process, making it accessible to users of all skill levels, from novices to experts. This cloud-based software automates the multidimensional clustering of flow cytometry data, representing a significant improvement over existing solutions that may not be as effective, regardless of the user's data processing abilities.
Why Purchase the Report?
• To visualize the global flow cytometry
Market Segmentation based on product type, technology, application, end-user, and region and understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the flow cytometry market with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping is available in excel consisting of key products of all the major players.
The global flow cytometry market report would provide approximately 70 tables, 65 figures, and 184 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Incidence of Chronic Diseases and Technological Advancements
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Equipment Costs
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. By Product Type
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
6.1.2. Market Attractiveness Index, By Product Type
6.2. Reagents and Consumables*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.2.3. Antibodies
6.2.4. Assays and kits
6.2.5. Others
6.3. Instruments
6.3.1. Cell Analyzers
6.3.2. Cell Sorters
6.4. Software
6.5. Accessories
6.6. Services
7. By Technology
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
7.1.2. Market Attractiveness Index, By Technology
7.2. Cell-Based *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bead-Based
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Research *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Drug Discovery
8.2.4. Stem Cell Research
8.2.5. Immunology Studies
8.2.6. Apoptosis Analysis
8.2.7. Cell Sorting and Viability Assessments
8.3. Clinical
8.3.1. Cancer Detection
8.3.2. Organ Transplantation
8.3.3. Immunodeficiency Disorders
8.3.4. Hematology
8.4. Industrial
9. By End-User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Pharmaceutical & Biotechnology Companies*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Academic & Research Institutes
9.4. Hospitals & Clinical Testing Laboratories
9.5. Blood Banks
9.6. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.7.1. U.S.
10.2.7.2. Canada
10.2.7.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.7.1. Germany
10.3.7.2. U.K.
10.3.7.3. France
10.3.7.4. Spain
10.3.7.5. Italy
10.3.7.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.7.1. Brazil
10.4.7.2. Argentina
10.4.7.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.7.1. China
10.5.7.2. India
10.5.7.3. Japan
10.5.7.4. South Korea
10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Becton, Dickinson and Company *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Danaher Corporation (Beckman Coulter)
12.3. Thermo Fisher Scientific Inc.
12.4. Agilent Technologies, Inc.
12.5. Bio-Rad Laboratories, Inc.
12.6. Miltenyi Biotec
12.7. Sysmex Corporation
12.8. bioMérieux
12.9. Cytek Biosciences
12.10. Apogee Flow Systems Ltd.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us
❖ 世界のフローサイトメトリー市場に関するよくある質問(FAQ) ❖
・フローサイトメトリーの世界市場規模は?
→DataM Intelligence社は2023年のフローサイトメトリーの世界市場規模を47.6億米ドルと推定しています。
・フローサイトメトリーの世界市場予測は?
→DataM Intelligence社は2031年のフローサイトメトリーの世界市場規模を82.4億米ドルと予測しています。
・フローサイトメトリー市場の成長率は?
→DataM Intelligence社はフローサイトメトリーの世界市場が2024年~2031年に年平均7.1%成長すると予測しています。
・世界のフローサイトメトリー市場における主要企業は?
→DataM Intelligence社は「Becton、Dickinson and Company、Danaher Corporation(Beckman Coulter)、Thermo Fisher Scientific Inc.、Agilent Technologies, Inc.、Bio-Rad Laboratories, Inc.、Miltenyi Biotec、Sysmex Corporation、bioMérieux、Cytek Biosciences、Apogee Flow Systems Ltd.など ...」をグローバルフローサイトメトリー市場の主要企業として認識しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。